An estimated six million people worldwide are living with Parkinson’s disease. 
No Cure
Over the last decade, 23andMe researchers and our collaborators have made important strides. We now have a better understanding of the causes and progression of the disease.
Parkinson’s Research
Now 23andMe’s Parkinson’s Research Community is by far the largest cohort of its kind. Participants in this research, are both re-contactable and deeply phenotyped. It has become an enormous resource for Parkinson’s research.
Preliminary Results from the Parkinson’s Impact Baseline Survey
By Eli Chanoff, 23andMe Research AssociateParkinson’s disease (PD) has been a central focus of 23andMe’s research since our company’s early years. Over more than a decade, we have grown a...
Read More
Large Study Offers Insight into Parkinson’s
Using data from four million 23andMe research participants, scientists studying Parkinson's disease made new findings that may help efforts by drug hunters looking for ways to treat the disease. The study also included data from the Broad Institute's Genome Aggregation Database (gnomAD) and was one of seven published in the journal Nature Medicine that leverage this data meant to bring together exome and sequence data from many sources for researchers.
Read More
23andMe’s Parkinson’s Research Community, More than a Decade of Discovery
As part of Parkinson's Awareness month, 23andME looks back over the now 11 years since we formed the Parkinson's Research Community and note some of what we've accomplished.
Read More
Powering Parkinson’s Research with My Blueprint
Claudia shares her perspective on living with Parkinson's and on why she participates in Parkinson's research in this post that first appeared on the Michael J. Fox Foundation blog.
Read More
Participating in 23andMe Research, A Customer’s Perspective
23andMe research participant Tony Garrett gives his perspective on why he is participating in research and his hopes for the future.
Read More
New Parkinson’s Disease Research May Offer Promise for Early Detection
New Parkinson’s disease research by scientists at 23andMe has identified more than 100 phenotypic variables related to the disease, offering a potential step forward in efforts to diagnose Parkinson’s disease...
Read More
October Insights into Parkinson’s Research
An update on recruitment for the Fox Insights Parkinson's research initiative.
Read More
An Interview with 23andMe’s Parkinson’s disease program Manager Paul Cannon
23andMe's Parkinson's research community manager, Paul Cannon shares his experience with Deep Brain Stimulation to treat his Parkinson's symptoms.
Read More
New Parkinson’s Disease Research Collaboration with the Michael J. Fox Foundation
As part of a broad collaboration with the Michael J. Fox Foundation, 23andMe is inviting participants in its Parkinson's Research community to participate in a new initiative called Fox Insights to make data broadly available to qualified researchers worldwide starting in 2018, with the goals of sparking innovation and discoveries around Parkinson’s disease.
Read More
Update on 23andMe Parkinson’s disease research
Participants in the 23andMe Parkinson’s disease research initiative have contributed a vast amount of data, that has enabled our researchers and collaborators to improve our understanding of the genetics of...
Read More